These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24736554)

  • 21. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
    Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
    Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
    Chen JT; Yao KH; Hua L; Zhang LP; Wang CY; Zhang JJ
    Int J Clin Exp Pathol; 2015; 8(9):10922-8. PubMed ID: 26617808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone-related protein regulates integrin α6 and β4 levels via transcriptional and post-translational pathways.
    Bhatia V; Mula RV; Falzon M
    Exp Cell Res; 2013 Jun; 319(10):1419-30. PubMed ID: 23499737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
    Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
    Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.
    Xu K; Liang X; Shen K; Sun L; Cui D; Zhao Y; Tian J; Ni L; Liu J
    Exp Cell Res; 2012 Oct; 318(17):2168-77. PubMed ID: 22677042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromogenic in situ hybridization for alpha6beta4 integrin in breast cancer: correlation with protein expression.
    Diaz LK; Zhou X; Welch K; Sahin A; Gilcrease MZ
    J Mol Diagn; 2004 Feb; 6(1):10-5. PubMed ID: 14736821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rac1-mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
    Mori K; Higurashi M; Ishikawa F; Shibanuma M
    Cancer Sci; 2021 Aug; 112(8):3205-3217. PubMed ID: 34036687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients.
    Doberstein K; Steinmeyer N; Hartmetz AK; Eberhardt W; Mittelbronn M; Harter PN; Juengel E; Blaheta R; Pfeilschifter J; Gutwein P
    Neoplasia; 2013 Feb; 15(2):218-30. PubMed ID: 23441135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.
    Pinatel EM; Orso F; Penna E; Cimino D; Elia AR; Circosta P; Dentelli P; Brizzi MF; Provero P; Taverna D
    PLoS One; 2014; 9(1):e84859. PubMed ID: 24400121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
    Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
    J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
    Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
    J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1.
    Gu Y; Cheng Y; Song Y; Zhang Z; Deng M; Wang C; Zheng G; He Z
    PLoS One; 2014; 9(8):e102602. PubMed ID: 25105419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role of STAT5a in DCIS formation and invasion following estrogen treatment.
    Dees S; Pontiggia L; Jasmin JF; Sotgia F; Lisanti MP; Mercier I
    Aging (Albany NY); 2020 Aug; 12(14):15104-15120. PubMed ID: 32633727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.
    Draheim KM; Chen HB; Tao Q; Moore N; Roche M; Lyle S
    Oncogene; 2010 Sep; 29(36):5032-47. PubMed ID: 20603614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo.
    Lipscomb EA; Simpson KJ; Lyle SR; Ring JE; Dugan AS; Mercurio AM
    Cancer Res; 2005 Dec; 65(23):10970-6. PubMed ID: 16322245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
    Citron F; Segatto I; Vinciguerra GLR; Musco L; Russo F; Mungo G; D'Andrea S; Mattevi MC; Perin T; Schiappacassi M; Massarut S; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
    Cancer Res; 2020 Mar; 80(5):1064-1077. PubMed ID: 31862778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.
    Wang D; Huang J; Hu Z
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
    Tan SH; Nevalainen MT
    Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.